New perspectives on molecular targeted therapy in ovarian clear cell carcinoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New perspectives on molecular targeted therapy in ovarian clear cell carcinoma
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 108, Issue 8, Pages 1553-1559
Publisher
Springer Nature
Online
2013-04-05
DOI
10.1038/bjc.2013.126
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bevacizumab in the Treatment of Ovarian Cancer
- (2012) Florian Heitz et al. ADVANCES IN THERAPY
- Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma
- (2012) Munmun Rahman et al. HUMAN PATHOLOGY
- Navitoclax (ABT-263) Reduces Bcl-xL-Mediated Chemoresistance in Ovarian Cancer Models
- (2012) M. Wong et al. MOLECULAR CANCER THERAPEUTICS
- Patient-derived tumour xenografts as models for oncology drug development
- (2012) John J. Tentler et al. Nature Reviews Clinical Oncology
- Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer
- (2012) A. H. Shain et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunohistochemical expression of VEGF predicts response to platinum based chemotherapy in patients with epithelial ovarian cancer
- (2011) G. K. Siddiqui et al. ANGIOGENESIS
- ARID1A, a Factor That Promotes Formation of SWI/SNF-Mediated Chromatin Remodeling, Is a Tumor Suppressor in Gynecologic Cancers
- (2011) B. Guan et al. CANCER RESEARCH
- IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer
- (2011) M. S. Anglesio et al. CLINICAL CANCER RESEARCH
- Genomic Analysis Reveals the Molecular Heterogeneity of Ovarian Clear Cell Carcinomas
- (2011) David S.P. Tan et al. CLINICAL CANCER RESEARCH
- Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010
- (2011) Michael S. Anglesio et al. GYNECOLOGIC ONCOLOGY
- Ovarian cancer linked to lynch syndrome typically presents as early-onset, non-serous epithelial tumors
- (2011) Zohreh Ketabi et al. GYNECOLOGIC ONCOLOGY
- Class III β-tubulin expression in advanced-stage serous ovarian carcinoma effusions is associated with poor survival and primary chemoresistance
- (2011) Thea Eline Hetland et al. HUMAN PATHOLOGY
- Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors
- (2011) Leena Gandhi et al. JOURNAL OF CLINICAL ONCOLOGY
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- (2011) Timothy A. Yap et al. JOURNAL OF CLINICAL ONCOLOGY
- PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma
- (2011) Sohei Yamamoto et al. JOURNAL OF PATHOLOGY
- Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancer
- (2011) Rodrigo Dienstmann et al. Molecular Oncology
- Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder
- (2011) Yaoting Gui et al. NATURE GENETICS
- An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer
- (2011) A Mamo et al. ONCOGENE
- Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers
- (2011) Michael P. Stany et al. PLoS One
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
- (2010) Robert J. Kurman et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer
- (2010) Helen J. Mackay et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
- (2010) Ahmed Ashour Ahmed et al. JOURNAL OF PATHOLOGY
- Vascular Endothelial Growth Factor Is a Promising Therapeutic Target for the Treatment of Clear Cell Carcinoma of the Ovary
- (2010) Seiji Mabuchi et al. MOLECULAR CANCER THERAPEUTICS
- ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas
- (2010) Kimberly C. Wiegand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes
- (2010) K Yamaguchi et al. ONCOGENE
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
- (2010) Siân Jones et al. SCIENCE
- PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP Inhibitors
- (2010) K. J. Dedes et al. Science Translational Medicine
- A Current Review of Targeted Therapeutics for Ovarian Cancer
- (2010) Susana M. Campos et al. Journal of Oncology
- Precursor Lesions of High-Grade Serous Ovarian Carcinoma: Morphological and Molecular Characteristics
- (2010) Amy L. Gross et al. Journal of Oncology
- Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma
- (2009) Kuan-Ting Kuo et al. AMERICAN JOURNAL OF PATHOLOGY
- mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary
- (2009) S. Mabuchi et al. CLINICAL CANCER RESEARCH
- PPM1D Is a Potential Therapeutic Target in Ovarian Clear Cell Carcinomas
- (2009) D. S.P. Tan et al. CLINICAL CANCER RESEARCH
- Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair geneMSH2
- (2009) Sarah A. Martin et al. EMBO Molecular Medicine
- Tumor type and substage predict survival in stage I and II ovarian carcinoma: Insights and implications
- (2009) Martin Köbel et al. GYNECOLOGIC ONCOLOGY
- The SWI/SNF complex and cancer
- (2009) D Reisman et al. ONCOGENE
- A Limited Panel of Immunomarkers Can Reliably Distinguish Between Clear Cell and High-grade Serous Carcinoma of the Ovary
- (2008) Martin Köbel et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The type 2C phosphatase Wip1: An oncogenic regulator of tumor suppressor and DNA damage response pathways
- (2008) Xiongbin Lu et al. CANCER AND METASTASIS REVIEWS
- Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias
- (2008) Danilo Perrotti et al. CANCER AND METASTASIS REVIEWS
- Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma
- (2008) Hiroaki Itamochi et al. CANCER SCIENCE
- Systematic Review and Meta-analysis of Ovarian Cancers: Estimation of Microsatellite-High Frequency and Characterization of Mismatch Repair Deficient Tumor Histology
- (2008) T. Pal et al. CLINICAL CANCER RESEARCH
- Contents of Endometriotic Cysts, Especially the High Concentration of Free Iron, Are a Possible Cause of Carcinogenesis in the Cysts through the Iron-Induced Persistent Oxidative Stress
- (2008) K. Yamaguchi et al. CLINICAL CANCER RESEARCH
- Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers
- (2008) John K. Chan et al. GYNECOLOGIC ONCOLOGY
- Low response rate of second-line chemotherapy for recurrent or refractory clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study
- (2008) M. TAKANO et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- ES cell pluripotency and germ-layer formation require the SWI/SNF chromatin remodeling component BAF250a
- (2008) X. Gao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started